November 2023 Newsletter
Safe Biologics
DECEMBER 3, 2023
The most recen t of the webinars, hosted July 29th, examined the negative impact of the Inflation Reducation Act’s Medicare drug price setting provisions. The guidance removed the interchangeability statement from the product label/package insert of interchangeable biosimilars.
Let's personalize your content